Therapy Optimization in Multiple Sclerosis (MS)

NCT00819000 · clinicaltrials.gov ↗

COMPLETED

Status

2878

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b

Sponsor

Teva Neuroscience, Inc.